After a lifetime of research, a Frenchman awarded for having found the cause of narcolepsy

After a lifetime of research, a Frenchman awarded for having found the cause of narcolepsy

It is a disease “rare”, “unbelievable”, but also “devastating”including patients with “suffering terribly”. The Frenchman Emmanuel Mignot has dedicated his career to the study of narcolepsy, until he found the cause and thus shed some light on one of the great mysteries of biology: sleep.

Drugs in development

His discovery, in the heart of the meanderings of our brain, has today earned him the award with an important American prize, the Breakthrough Prize, together with the Japanese Masashi Yanagisawa, who reached similar conclusions at the same time.

Thanks to this research, drugs are now being developed that promise to revolutionize the treatment of narcolepsy and other sleep disorders.

Narcoleptics, about one in 2,000 people, can’t help but suddenly fall asleep in the middle of the day. Some are also affected by sudden temporary paralysis (cataplexy).

“I am very proud, because what I discovered is making a big difference for my patients. It’s the best reward you can get.” This professor from Stanford University in California confides in AFP, where narcoleptics from all over the world come to consult him.

Thirty years ago, a young medicine and science graduate, Emmanuel Mignot decided to travel to the United States during his military service, in order to study the operation of a drug then used against narcolepsy.

At that time, this disease was “virtually unknown” Y “nobody studied it”, remember. But is he “He was completely fascinated.”

“I said to myself, this disease is amazing, people fall asleep all the time, we have no idea why, and if we could find the cause, we could understand something new about sleep.” explains the 63-year-old researcher.

missing key

Stanford then has narcoleptic dogs and sets out to find the gene that causes the disease in them.

A titanic undertaking, because genome sequencing techniques were primitive at the time. “Everyone told me I was crazy” he remembers Mr. Mignot, who now lives with a narcoleptic dog, Watson, whom he adopted. “I thought it was going to take a few years, and it took 10 years. »

Finally, in 1999, the finding: a receptor located in the brain cells of narcoleptic dogs is abnormal.

This receptor is like a lock, which only reacts in the presence of the correct key: a molecule discovered at the same time by the Japanese Masashi Yanagisawa, who named it orexin (also sometimes called hypocretin). It is a neurotransmitter produced in the hypothalamus, at the base of the brain, by a very small population of neurons.

Immediately, Emmanuel Mignot carried out the first tests on humans. And the results are impressive: orexin levels in the brains of narcoleptic patients are zero.

However, in normal times, this molecule is produced in large quantities throughout the day, especially at night, which makes it possible to fight against accumulated fatigue.

The path of action of the disease is therefore similar: in dogs, the lock is broken, but in humans, the key is missing. Which also explains why the disease can be inherited in dogs, not humans.

“You don’t make a discovery like that twice in your life. We find the cause of a disease, the Frenchman marvels. “The advantage is that the key, we can remake it. »

“miraculous” treatment

At the moment, most patients are treated with a combination of anesthetics to put them into a deep sleep at night and amphetamines to wake them up during the day.

But by administering a drug that mimics orexin in trials, the results are “truly miraculous”says Mr. Mignot. Patients then have “different eyes” They are “just woke up, calm down”, a truly “transformation. »

The current challenge remains to develop the formulation that provides the right dose at the right time. Several companies, including Japan’s Takeda, are working on the issue, and the drugs could be licensed in the next few years.

Applications for other diseases are also possible: for example, for depressed patients who have difficulty getting up, or in a coma and with difficulty waking up, says the researcher.

Not all questions are answered. Emmanuel Mignot is now trying to prove that narcolepsy is caused by the flu virus.

According to him, the immune system, which is responsible for defending us against infections, can begin to confuse orexin-producing neurons with certain flu viruses, and end up attacking them. However, once dead, these neurons cannot be renewed and patients will no longer be able to produce orexin for life.

More broadly, “I became interested in how the immune system works in the brain”say, a domain “exploding”.

As for the mystery of the dream, although he has elucidated one of its main mechanisms, the researcher still admits to being fascinated: “What does sleep do that is so important that we need to do it every day? »he wonders. “It is true that we still do not understand. »

#lifetime #research #Frenchman #awarded #narcolepsy

Leave a Comment

Your email address will not be published. Required fields are marked *